URL has been copied successfully!
Shares of Kyverna Therapeutics Inc (NASDAQ:KYTX) rose sharply in pre-market trading after releasing positive registrational trial results for miv-cel in stiff person syndrome at the American Academy of Neurology Annual Meeting in Chicago.
Miv-cel, the single-dose CAR T-cell therapy met its primary endpoint, delivering a statistically significant 46% median improvement in the Timed 25-Foot Walk at 16 weeks.
Kyverna Therapeutics shares jumped 25.8% to $12.21 in pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers
- Huachen AI Parking Mgmt Tech Hldg Co Ltd (NASDAQ:HCAI) gained 97% to $13.37 in pre-market trading after gaining more than 23% on Tuesday.
- eLong Power Holding Ltd (NASDAQ:ELPW) gained 42.1% to $2.23 in pre-market trading after falling 9% on Tuesday.
- AlphaTON Capital Corp (NASDAQ:ALP) rose 35.4% to $0.38 in pre-market trading.
- FST Ltd (NASDAQ:KBSX) jumped 30.4% to $0.37 in pre-market trading. FST announced preliminary 31% FY 2025 revenue increase from $36.5 million to $47.97 million.
- Aspire Biopharma Holdings Inc (NASDAQ:ASBP) rose 19.2% to $0.23 in pre-market trading …
Please follow us:
This post was originally published here
